Cargando…
Neonatal Exendin-4 Reduces Growth, Fat Deposition and Glucose Tolerance during Treatment in the Intrauterine Growth-Restricted Lamb
BACKGROUND: IUGR increases the risk of type 2 diabetes mellitus (T2DM) in later life, due to reduced insulin sensitivity and impaired adaptation of insulin secretion. In IUGR rats, development of T2DM can be prevented by neonatal administration of the GLP-1 analogue exendin-4. We therefore investiga...
Autores principales: | Gatford, Kathryn L., Sulaiman, Siti A., Mohammad, Saidatul N. B., De Blasio, Miles J., Harland, M. Lyn, Simmons, Rebecca A., Owens, Julie A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570470/ https://www.ncbi.nlm.nih.gov/pubmed/23424667 http://dx.doi.org/10.1371/journal.pone.0056553 |
Ejemplares similares
-
Correction: Neonatal Exendin-4 Reduces Growth, Fat Deposition and Glucose Tolerance during Treatment in the Intrauterine Growth-Restricted Lamb
Publicado: (2014) -
Placenta: chronicle of intrauterine growth restriction
por: Dicke, Jeffrey M
Publicado: (2010) -
Intrauterine growth restriction and placental angiogenesis
por: Barut, Figen, et al.
Publicado: (2010) -
Predictive factors for intrauterine growth restriction
por: Albu, AR, et al.
Publicado: (2014) -
Intrauterine Growth Restriction and Cerebral Palsy
por: Kurjak, Asim, et al.
Publicado: (2010)